Peter Boyce

Peter Boyce has worked for a number of companies since 2008, starting with Novartis Animal Health US, Inc. as a Scientist. In 2009, they moved to GSK as an Investigator. Peter then went to MedImmune in 2018 as an R&D Manager and continued in the same role at AstraZeneca from 2019 to 2022. Peter is currently employed as an Associate Director at AviadoBio.

Peter Boyce completed a Bachelor's degree in Biological and Biomedical Sciences from Nottingham Trent University between 2000 and 2002. Peter then went on to complete a Master of Science in Biomedical Sciences, General from Nottingham Trent University between 2002 and 2003. Finally, they completed a Master of Philosophy in Oncology and Cancer Biology from the University of Nottingham in 2007.